XML 33 R23.htm IDEA: XBRL DOCUMENT v3.22.1

Net Loss Per Share (Tables)

3 Months Ended

Mar. 31, 2022

Earnings Per Share [Abstract]

Summary of Dilutive Securities Not Included in the Diluted Net Loss Per Common Share

The table below provides potentially dilutive securities not included in the calculation of the diluted net loss per common share because to do so would be anti-dilutive:

		Three Months Ended March 31,
		2022				2021
Shares issuable upon exercise of stock options			4,922,019				3,481,178
Shares issuable upon conversion of Series A Preferred Stock			—				477,297
Shares issuable upon conversion of Series A-1 Preferred Stock			—				7,537,879
Shares issuable upon conversion of Series B Preferred Stock			—				11,862,043
Shares issuable upon exercise of common stock warrants			—				385,693
Shares issuable upon exercise of preferred stock warrant			—				447,426
Total			4,922,019				24,191,516

X

- References

No definition available.

+ Details

Name:	us-gaap_EarningsPerShareAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257

+ Details

Name:	us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration